Literature DB >> 9728940

Evidence of CNS impairment in HIV infection: clinical, neuropsychological, EEG, and MRI/MRS study.

M J Harrison1, S P Newman, M A Hall-Craggs, C J Fowler, R Miller, B E Kendall, M Paley, I Wilkinson, B Sweeney, S Lunn, S Carter, I Williams.   

Abstract

OBJECTIVES: To identify by clinical examination, EEG, MRI, and proton spectroscopy, and neuropsychological assessment the prevalence of signs of CNS involvement in patients infected with HIV, and to relate such findings to the evidence of immunosuppression.
METHODS: The design was a cross sectional analysis of a cohort of male patients with infected HIV with an AIDS defining diagnosis or low CD4 count (<350), and seropositive asymptomatic subjects, both groups being followed up in a longitudinal study. Control groups consisted of seronegative subjects from the same genitourinary medicine clinics.
RESULTS: This report sets out the cross sectional findings at the seventh visit in the longitudinal study. Patients with AIDS had more signs of neurological dysfunction, poorer performance on a neuropsychological test battery, were more likely to have an abnormal EEG, and to have abnormalities on MRI. They more often had cerebral atrophy, abnormal appearing white matter, and abnormal relaxometry and spectroscopy. There was little evidence of abnormality in seropositive people who had a CD4 count >350 compared with seronegative people from a similar background.
CONCLUSIONS: Detailed testing failed to disclose significant CNS impairment without immunosuppression in men infected with HIV. Findings from MRI and magnetic resonance spectroscopy (MRS) correlated with those of the neurological examination and neuropsychological assessment. A combination of such assessments offers a simple surrogate for studies of CNS involvement in HIV disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9728940      PMCID: PMC2170227          DOI: 10.1136/jnnp.65.3.301

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  39 in total

Review 1.  HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology.

Authors:  H Budka; C A Wiley; P Kleihues; J Artigas; A K Asbury; E S Cho; D R Cornblath; M C Dal Canto; U DeGirolami; D Dickson
Journal:  Brain Pathol       Date:  1991-04       Impact factor: 6.508

2.  Proton MRS and quantitative MRI assessment of the short term neurological response to antiretroviral therapy in AIDS.

Authors:  I D Wilkinson; S Lunn; K A Miszkiel; R F Miller; M N Paley; I Williams; R J Chinn; M A Hall-Craggs; S P Newman; B E Kendall; M J Harrison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

3.  Cerebral proton magnetic resonance spectroscopy in asymptomatic HIV infection.

Authors:  I D Wilkinson; R F Miller; K A Miszkiel; M N Paley; M A Hall-Craggs; T Baldeweg; I G Williams; S Carter; S P Newman; B E Kendall; J Catalan; R J Chinn; M J Harrison
Journal:  AIDS       Date:  1997-03       Impact factor: 4.177

4.  Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences.

Authors:  C Power; J C McArthur; R T Johnson; D E Griffin; J D Glass; S Perryman; B Chesebro
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

5.  Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings.

Authors:  W K Chong; B Sweeney; I D Wilkinson; M Paley; M A Hall-Craggs; B E Kendall; J K Shepard; M Beecham; R F Miller; I V Weller
Journal:  Radiology       Date:  1993-07       Impact factor: 11.105

6.  White matter changes in healthy elderly persons correlate with attention and speed of mental processing.

Authors:  R Ylikoski; A Ylikoski; T Erkinjuntti; R Sulkava; R Raininko; R Tilvis
Journal:  Arch Neurol       Date:  1993-08

7.  HIV-1 infection of subcortical astrocytes in the pediatric central nervous system.

Authors:  C Tornatore; R Chandra; J R Berger; E O Major
Journal:  Neurology       Date:  1994-03       Impact factor: 9.910

8.  Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) p24 antigen levels in HIV-1-related dementia.

Authors:  W Royal; O A Selnes; M Concha; T E Nance-Sproson; J C McArthur
Journal:  Ann Neurol       Date:  1994-07       Impact factor: 10.422

9.  Cerebrospinal fluid-intracranial volume ratio measurements in patients with HIV infection: CLASS image analysis technique.

Authors:  M N Paley; W K Chong; I D Wilkinson; J K Shepherd; A M Clews; B J Sweeney; M A Hall-Craggs; B E Kendall; S P Newman; M J Harrison
Journal:  Radiology       Date:  1994-03       Impact factor: 11.105

10.  Long-latency event-related potentials in asymptomatic human immunodeficiency virus type 1 infection.

Authors:  S Connolly; H Manji; R H McAllister; M Fell; C Loveday; C Kirkis; M Herns; B Sweeney; O Sartawi; P Durrance
Journal:  Ann Neurol       Date:  1994-02       Impact factor: 10.422

View more
  16 in total

Review 1.  The role of medical imaging in defining CNS abnormalities associated with HIV-infection and opportunistic infections.

Authors:  David F Tate; Rola Khedraki; Daniel McCaffrey; Daniel Branson; Jeffrey Dewey
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

2.  Acute EEG findings in HIV-infected Zambian adults with new-onset seizure.

Authors:  Omar K Siddiqi; Melissa A Elafros; Izukanji Sikazwe; Gretchen L Birbeck; Lisa Kalungwana; Michael J Potchen; Christopher M Bositis; Igor J Koralnik; William H Theodore
Journal:  Neurology       Date:  2015-03-04       Impact factor: 9.910

3.  Positron emission tomography imaging of peripheral benzodiazepine receptor binding in human immunodeficiency virus-infected subjects with and without cognitive impairment.

Authors:  Clayton A Wiley; Brian J Lopresti; James T Becker; Fernando Boada; Oscar L Lopez; John Mellors; Carolyn C Meltzer; Stephen R Wisniewski; Chester A Mathis
Journal:  J Neurovirol       Date:  2006-08       Impact factor: 2.643

4.  Interactive effects of HIV/AIDS, body mass, and substance abuse on the frontal brain: a P300 study.

Authors:  Lance O Bauer
Journal:  Psychiatry Res       Date:  2010-05-23       Impact factor: 3.222

5.  Cerebrospinal fluid tau concentrations in HIV infected patients with suspected neurological disease.

Authors:  A J Green; G Giovannoni; M A Hall-Craggs; E J Thompson; R F Miller
Journal:  Sex Transm Infect       Date:  2000-12       Impact factor: 3.519

6.  3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry.

Authors:  Ming-Chang Chiang; Rebecca A Dutton; Kiralee M Hayashi; Oscar L Lopez; Howard J Aizenstein; Arthur W Toga; James T Becker; Paul M Thompson
Journal:  Neuroimage       Date:  2006-10-10       Impact factor: 6.556

7.  Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapy.

Authors:  Victor Valcour; Michael R Watters; Andrew E Williams; Ned Sacktor; Aaron McMurtray; Cecilia Shikuma
Journal:  J Neurovirol       Date:  2008-11-12       Impact factor: 2.643

8.  Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains.

Authors:  Adarsh M Kumar; J B Fernandez; Elyse J Singer; Deborah Commins; Drenna Waldrop-Valverde; Raymond L Ownby; Mahendra Kumar
Journal:  J Neurovirol       Date:  2009-05       Impact factor: 2.643

9.  Cortical atrophy and white matter hyperintensities in HIV: the Hawaii Aging with HIV Cohort Study.

Authors:  Aaron McMurtray; Beau Nakamoto; Cecelia Shikuma; Victor Valcour
Journal:  J Stroke Cerebrovasc Dis       Date:  2008 Jul-Aug       Impact factor: 2.136

10.  HIV/AIDS and an overweight body mass are associated with excessive intra-individual variability in response preparation.

Authors:  Lance O Bauer
Journal:  J Neurovirol       Date:  2018-05-17       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.